Dec 03, 2020 / 01:50PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MD
Okay. Thanks, everyone, for joining us this morning. It's a real pleasure to have Medtronic with us. And representing the company, we have Mike Weinstein, Senior Vice President heading Strategy for the company. I know we have Ryan Weispfenning from Investor Relations in the background.
Mike, thank you so much for taking the time this morning. I mean, this must be -- I know for many years, you would ask the tough questions, so this is now with tables reversed, get ready for -- to be in the hot seat, but thank you so much for making the time this morning.
Michael Neil Weinstein - Medtronic plc - SVP of Strategy
Thanks for having me.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MDSo when I think about Medtronic, '21 is shaping up to be a really, really big year for Medtronic. But before we get into the catalyst, something that's been topical for us, investors, has
Trustpilot
